Verition Fund Management
FLGT icon

Verition Fund Management’s Fulgent Genetics FLGT Stock Holding History

Verition Fund Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-26,087
Closed -$685K – 2723
2025
Q4 		$685K Sell
26,087
-3,218
-11% -$83.5K ﹤0.01% 2434
2025
Q3 		$662K Sell
29,305
-3,442
-11% -$70.9K ﹤0.01% 2853
2025
Q2 		$651K Sell
32,747
-44,929
-58% -$876K ﹤0.01% 2772
2025
Q1 		$1.31M Buy
+77,676
New +$1.32M 0.01% 1908
2024
Q2 		– Sell
-12,244
Closed -$266K – 3074
2024
Q1 		$266K Buy
12,244
+1,144
+10% +$28.4K ﹤0.01% 2357
2023
Q4 		$321K Buy
+11,100
New +$297K ﹤0.01% 1766

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Verition Fund Management's FLGT Position: Q1 2026 in Review

Verition Fund Management sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 26,087 shares — an estimated $685K sold.

Verition Fund Management first reported a position in FLGT in Q4 2023 and held it in 6 quarters. The position peaked at $1.31M in Q1 2025. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Verition Fund Management reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 26,087 Fulgent Genetics shares in Q1 2026, an estimated $685K.
  • Verition Fund Management first reported a position in Fulgent Genetics in Q4 2023 and held it in 6 quarters.
  • Verition Fund Management's Fulgent Genetics position peaked at $1.31M in Q1 2025.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.